Hemostatic compositions and uses therefor

Details Hemostatic compositions and uses therefor Hemostatic compositions and uses therefor

2011-04-26

2011-04-26

Kidwell, Michele (Department: 3761)

Surgery

Means and methods for collecting body fluids or waste material

Absorbent pad for external or internal application and...

C604S390000

Reexamination Certificate

active

07931637

ABSTRACT:
The present invention relates generally to the field of hemostasis, including methods, compositions, and devices that can be employed to achieve hemostasis at an increased rate. More specifically the present invention relates to hemostatic compositions that achieve a hemostatic effect at a distance from the site of application of the composition, and a method for administering such a composition to effectively reduce localized vascular complications associated with treating a breach or puncture in a vein or artery and reduce the time to achieve hemostasis.

REFERENCES:
patent: 4394373 (1983-07-01), Malette et al.
patent: 5437292 (1995-08-01), Kipshidze et al.
patent: 5510102 (1996-04-01), Cochrum
patent: 5564849 (1996-10-01), Greer, Jr.
patent: 5622834 (1997-04-01), Vournakis et al.
patent: 5623064 (1997-04-01), Vournakis et al.
patent: 5624679 (1997-04-01), Vournakis et al.
patent: 5635493 (1997-06-01), Vournakis et al.
patent: 5686115 (1997-11-01), Vournakis et al.
patent: 5746755 (1998-05-01), Wood et al.
patent: 5846952 (1998-12-01), Vournakis et al.
patent: 5858350 (1999-01-01), Vournakis et al.
patent: 6056970 (2000-05-01), Greenawalt et al.
patent: 6063911 (2000-05-01), Vournakis et al.
patent: 6162241 (2000-12-01), Coury et al.
patent: 6193670 (2001-02-01), Van Tassel et al.
patent: 6361551 (2002-03-01), Torgerson et al.
patent: 6599720 (2003-07-01), Vournakis et al.
patent: 6610668 (2003-08-01), Vournakis et al.
patent: 6630459 (2003-10-01), Vournakis et al.
patent: 6649599 (2003-11-01), Vournakis et al.
patent: 6743783 (2004-06-01), Vournakis et al.
patent: 2002/0006429 (2002-01-01), Redmond et al.
patent: 2002/0197302 (2002-12-01), Cochrum et al.
patent: 2003/0078234 (2003-04-01), Vournakis et al.
patent: 2003/0129183 (2003-07-01), Spillert et al.
patent: 2004/0087015 (2004-05-01), Vournakis et al.
patent: 2001-513368 (2001-09-01), None
patent: WO 95/15343 (1995-06-01), None
patent: WO 99/07417 (1999-02-01), None
patent: WO 00/36918 (2000-06-01), None
patent: WO 02/063961 (2002-08-01), None
patent: WO 2004/060172 (2004-07-01), None
patent: WO 2004/076637 (2004-09-01), None
U.S. Appl. No. 60/437,349, filed Dec. 31, 2002, Vournakis et al.
Camenzind et al., 1994, “Collagen application versus manual compression: a prospective randomized trial for arterial puncture site closure after coronary angioplasty,” J. Am. Coll. Cardiol. 24(3):655-662.
Falstrom et al., 1997, “Reduction of femoral artery bleeding post catheterization using a collagen enhanced fibrin sealant,” Cathet. Cardiovasc. Diagn. 41(1):79-84.
Gwechenberger et al., 1997, “Use of a collagen plug versus manual compression for sealing arterial puncture site after cardiac catheterization,” Angiology 48(2):121-126.
Hoekstra et al., 1998, “Percutaneous microcrystalline chitosan application for sealing arterial puncture sites,” Biomaterials 19(16):1467-1471.
Ismail et al., 1995, “Reduction of femoral arterial bleeding post catheterization using percutaneous application of fibrin sealant,” Cathet. Cardiovasc. Diagn. 34(1):88-95.
Kipshidze et al., 1998, “Percutaneous Application of Fibrin Sealant to Achieve Hemostasis Following Arterial Catheterization,” J. Invasive Cardiol. 10(3):133-141.
Merino et al., 1992, “Percutaneous vascular hemostasis device for interventional procedures,” Cathet. Cardiovasc. Diagn. 26(4):319-322.
Olade et al., 2002, Emedicine Journal 3(3):1-13.
Prior et al., 2000, “Efficacy of a novel hemostatic agent in animal models of impaired hemostasis,” J. Biomed. Mater. Res. 53(3):252-257.
Sanborn et al., 1993, “A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty,” J. Am. Coll. Cardiol. 22(5):1273-1279.
Silber et al., 1998, “Usefulness of collagen plugging with VasoSeal after PTCA as compared to manual compression with identical sheath dwell times,” Cathet. Cardiovasc. Diagn. 43(4):421-427.
Meyer K.B. et al., 1999, “Control of post dialysis bleeding in patients on chronic oral anticoagulation therapy,” J Am Soc Nephrol 10:212A, Abtract A1078.
Nader R.G. et al., 2002, “Clinical evaluation of the SyvekPatch® in consecutive patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures,” J Invas Cardiol 14(6):305-307.
Najjar S.F. et al., 2004, “Evaluation of poly-N-acetyl glucosamine as a hemostatic agent in patients undergoing cardiac catheterization: a double-blind, randomized study,” J Trauma 57:S38-S41.
Roeder B.A.et al., 2002, “Self-sealing, large bore arterial punctures: a counterintuitive new phenomenon,” J. Biomech. Eng. 124(4):342-346.
Schrader R. et al., 1992, “Collagen application for sealing of arterial punture sites in comparison to pressare dressing: A randomized trial,” Catheteriz. and Cardiovasc. Diagnosis 27(4):298-302.
Shubrooks S.J. et al., 2000, “Earlier ambulation at 2 hours following cardiac catheterization using Syvek Patch®,” SCA&I 2000 Meeting Abstracts 143, Abstract PO22.
Smith T.P., et al., 2001, “Infectious complications resulting from use of hemostatic puncture closure devices,” A. J. Surg. 182(6):658-62.
Vournakis J.N. et al., 2003, “The RDH bandage: Hemostasis and Survival in a lethal aortotomy hemorrhage model,” J. Surg. Res. 113:1-5.
Yanagisawa M. et al., 1988, “A novel potent vasoconstrictor peptide produced by vascular endothelial cells,” 332:411-415.
Saishin Igaku Daijiten (Current Medical Dictionary), 2001, p. 24 and p. 687, in Japanese with translation of relevant paragraphs.
Written Opinion for Intern. Appl. No. PCT/US03/41762, mailed Sep. 9, 2004 by International Preliminary Examining Authority.
Inernational Preliminary Report on Patentability for Intern. Appl. No. PCT/US03/41762, mailed Mar. 16, 2009 by International Preliminary Examining Authority.

Affiliated with

Also associated with

Rating

Hemostatic compositions and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hemostatic compositions and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hemostatic compositions and uses therefor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2633058